Using Technology to Track Pain and Pain-related Outcomes
NCT04267588 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2025-06-29
Summary
Persistent pain is a public health epidemic. The current protocol seeks to develop technology to aid patients' tracking of patients' pain, medications and pain-related variables. The investigators seek to talk with patients in co-investigator's clinic to solicit feedback, as well as pilot test the technology with pain patients.
Conditions
- Pain, Chronic
Interventions
- OTHER
-
Navio Mobile App
Participants will use the Navio Mobile App to track participants' pain and pain treatment
Sponsors & Collaborators
-
PainCare, LLC
collaborator UNKNOWN - lead OTHER
Principal Investigators
-
Luis F Buenaver, Ph. D · Johns Hopkins University
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-08-10
- Primary Completion
- 2026-06-30
- Completion
- 2026-06-30
Countries
- United States
Study Locations
More Related Trials
-
Investigating Composite Biomarkers for Pain Catastrophizing
NCT04787198 ·Status: RECRUITING ·Phase: NA
-
Manage My Pain at Chronic Pain Clinics
NCT04762329 ·Status: COMPLETED ·Phase: NA
-
Subjective Observational Study of Patients Using Transdermal Cream Medication And/Or Transdermal Patches With Or Without Oral Non-Narcotic Medications
NCT03768011 ·Status: UNKNOWN
-
Pharmacokinetics and Pharmacodynamics of TRV130, Morphine, and Placebo in Healthy Subjects
NCT02083315 ·Status: COMPLETED ·Phase: PHASE1
-
Attenuation of Pain in Men and Women
NCT01220414 ·Status: COMPLETED ·Phase: NA
-
Targin® for Chronic Pain Management in Patients With Spinal Cord Injury
NCT03179475 ·Status: COMPLETED ·Phase: PHASE4
-
Precision Medicine Guided Treatment for Cancer Pain
NCT02664350 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Oxmorphone Extended Release in Chronic Non-malignant Pain
NCT00225797 ·Status: COMPLETED ·Phase: PHASE3
-
Role of the Endogenous Opioid System Underlying Modulation of Experimental Pain
NCT01327326 ·Status: WITHDRAWN ·Phase: NA
-
A Open-label Study to Evaluate the Safety of TRV130 in Patients With Acute Pain
NCT02656875 ·Status: COMPLETED ·Phase: PHASE3
-
Stepped Care to Optimize Pain Care Effectiveness
NCT00926588 ·Status: COMPLETED ·Phase: PHASE3
-
Brain Response to Pain Control in People With Chronic Pain
NCT01878019 ·Status: COMPLETED
-
Pharmacokinetic Study of Hydrocodone/APAP in Chronic Pain Patients
NCT01517295 ·Status: COMPLETED ·Phase: PHASE4
-
Reduced Opioid Analgesic Requirements Via Improved Endogenous Opioid Function
NCT02469077 ·Status: COMPLETED ·Phase: NA
-
PainSquad+: A Smartphone App to Support Real-time Pain Management for Adolescents With Cancer
NCT02901834 ·Status: COMPLETED
-
Ketamine Patient-Controlled Analgesia for Acute Pain
NCT02062879 ·Status: TERMINATED ·Phase: PHASE3
-
Using m-Health Tools to Reduce the Misuse of Opioid Pain Relievers
NCT03012087 ·Status: COMPLETED ·Phase: NA
-
S1916 Digital Medicine Program for Pain Control in Cancer Patients
NCT04194528 ·Status: TERMINATED ·Phase: NA
-
A Study of the Efficacy and Safety of Tramadol HCl/Acetaminophen, Hydrocodone Bitartrate/Acetaminophen and Placebo in Patients With Pain From an Ankle Sprain With a Partial Torn Ligament
NCT00236535 ·Status: COMPLETED ·Phase: PHASE3
-
Application Software in Dosage Adjustment for Advanced Cancer Patients With Pain
NCT03016364 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Reduction in Pain Intensity Following IV or Oral Pain-relieving Products
NCT02678416 ·Status: COMPLETED ·Phase: PHASE4
-
Phase 3 Study of Tramadol Hydrochloride/Acetaminophen SR Tab. & Tramadol Hydrochloride/Acetaminophen Tab. in Low Back Pain Patients
NCT01776515 ·Status: COMPLETED ·Phase: PHASE1
-
Safety Study of Oxycodone Hydrochloride and Naltrexone Hydrochloride Extended-Release Capsules in Subjects With Moderate to Severe Chronic Noncancer Pain
NCT01428583 ·Status: COMPLETED ·Phase: PHASE3
-
A Brief Intervention for Patients on Opioids for Acute Pain
NCT05658926 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Oxycodone/Naloxone (Targin®) in Persistent Moderate to Severe Low Back Pain Following NSAIDs Treatment
NCT03768466 ·Status: COMPLETED ·Phase: PHASE4